# Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma

> **NCT07377747** · — · RECRUITING · sponsor: **Australia and New Zealand Sarcoma Association** · enrollment: 100 (estimated)

## Conditions studied

- Retroperitoneal Liposarcoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07377747
- **Lead sponsor:** Australia and New Zealand Sarcoma Association
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-05
- **Primary completion:** 2032-12
- **Final completion:** 2032-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07377747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07377747, "Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07377747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*